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The integration sites in the cellular genome of human papillomavints are located in chromosomal regions always associated with oncogenes or 
other known tumor phenotypes. Two regions. 8q24 and 12ql3. are common to several cases of cervical carcinoma nd can have integrated more 
than one type of papillomavirus DNA. These two chromosomal regions contain several genes implicated in oncogenesis. These observations strongly 
imply that vi~l integration sites of DNA tumor viruses can be used as the access point to chromosomal regions where genes implicated in the tumor 
phenotype are located, a situation similar to that of non-transforming retroviruses. 
Papillomavirus: Oncogen; Tumor phenotype 
I. INTRODUCTION 
The oncogenic process is [he ,~sult of the sequential 
acct,mulation f mutations, some of which are selected 
for the new biological properties of the affected cell. 
These mutations will result in the development of a 
tumor and more importantly lead to the appearance of
tumor cell variants that give rise, among others, to me- 
tastasizing cells. The mutations are variable and can 
range from point mutations like in the ras gene family 
[1] to gross chromosomal aberrations like transloca- 
tions or deletions [2]. in many cases the mutation ob- 
served is a characteristic ofa specific type of tumor, but 
this does not imply that it is the only one. At least six 
different genetic alterations have recently been found in 
colon carcinoma [3]. In different umors the nature of 
the mutagenic agent may be different but not its conse- 
quences. 
About twenty percent of human tumors are associ- 
ated with the presence of  a virus [4]. Human papil- 
lomaviruses (HPV) are linked to the development of 
cervical carcinoma nd some skin carcinomas [4,5]. On 
a world-wide basis cervical carcinoma is the second type 
of cancer in women [5,6]. In advanced stages of  cervical 
carcinoma  common observation is the integration of 
the viral DNA into the cellular genome, but its role is 
poorly defined. This integration ;.s not part of  the life 
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cycle of the virus, however it is a clonality marker of the 
individual tumor. The integration of these viruses par- 
tially destroys the structure of the viral genes, some of 
which are no longer functional. If these integration sites 
were selected they might become markers for the loca- 
tion of a chromosomal region where genes implicated 
in oncogenesis might be located. Nevertheless it is not 
clear what the contribution of the integration to the 
tumor phenotype is. One way to provide an answer is 
by reviewing the location of the integration sites and see 
whether they are in regions associated with an onco- 
genie phenotype or a particular type of gene. Tumors 
associated with DNA tumor viruses have a long ~atency 
period which might be the result of the time needed to 
get integrations in the "proper' locus for tumor develop- 
ment. The observation of multiple chromosomal 
regions of viral DNA integration may hoa cons~ quLncc 
of the multigenc process of tumorigenesis and the 
biological step where integration takes place. 
In the better known process of  oncogenesis by non- 
transforming retroviruses, at least twenty genes impli- 
cated in oncogenesis are affected by provirus insertion 
[7,8]. Another twenty chromosomal regions have been 
identified as common regions of provirus integration. 
some of them are implicated in the l~te stages of onco- 
genesis like tumor progression, metastasis, and in the 
selection of specific tumor cell subpopulations for 
reasons not yet identified [7,8] In these tumors there is 
always a long latency period and in order to identify' 
these loci many tunl~., ~ ~w~, ,c to be examined before they 
are detected as ¢omm~,~ integration sites. To under- 
stand the action of the provirus mechanistically it is 
important to nc,,'ice that a provirus can alter the ~gula- 
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tion of  a gene at a distance greater than ~ kb [9] and 
that a @ wovirus can affect s~ 'a l  genes on the 
same dumnosmne[g J0 ] . -C~ from a biologi- 
cal point ~,w.  integration o f  an RNA or DNA tumor 
• ,irus can havethe same effe¢~ although thor integra- 
tion modmnim~ are diffet,~t. 
iI%~I'EGRATION REGIONS OF HUMAN 
PAPILLOMAV1RUSES DNA 
Human pap~maas~ruses form a group of  viruses 
with more than sixty different types based on their nu- 
clcofide sequence. These types have different properties 
based on their oncogenk: potential and the type of  epi- 
tlmlium ~4tere they are more freqtamfly ocalized. Only 
four ~a i  Lypes, HPV-16, HPV-18. HPV-31 and HPV- 
33. are associated with ox~r ninety percent of  cervical 
carcinomas [i !1. 
The integration of  HPV DNA is usually detected in 
advanced cancers. Nevertheless, in one case the integra- 
tion was already detected in a premalignat lesion [12], 
perhaps because the inlegration in the oncogenic loca- 
tion took place early on and was subsequently selected. 
In set,), few carcinomas rdated to HPV the integration 
of the viral DNA has been studied. Fortunately the 
mapping of the integration sites has been performed in 
a sufficient number of  cases to be able to draw some 
conclusions [ 12-17]. Also. several cell lines deft red from 
cervical carcinoma have been established and the chro- 
mosomal location of  the integrmed viral DNA deter- 
mined [13.15.1g-24]. The data is summarized in Table 
I. All the intg-grated viruses have in common their loca- 
tion on chromosomal regions known to contain an on- 
cogene or being associated with some other tumor 
patholoID*. The most striking observation, particularly 
in view of the very few cases studied, is the detection of 
two chromosomal regions. 8q24 and 12ql 3. with in- 
tegrated viral DNA of two different tH~'s. HPV-! 6 and 
18. in s~-eral cases. 
gq24 IS A CO.MMO?q INTEGRATION SiTE 
The chromosomal region 8¢124 contains at least four 
loci impl/cated in tumorigenesis: the oncogen c-myc. 
and the loci pal-l, mlri-! and mh'i-4. The locus pal-I 
codes for 5 and 10 kb messages (E.F.. P.A.L., unpub- 
lished) and is expressed in several tumor o~11 lines 
|!924]. Tbe mlri-|/prt [9J and mlri-4 [101 loci. initially 
idcmifmd as common regions of provirus inse~ion, arc 
located _~0 and 30 Eb 3" of c-rare, respectively. The 
mh'i.4 Ioc~ls ¢od~ for two messages of 3 and 5.5 kb 
which a~ !.tcnpho___id ~f~ lint ~ ,~ . . . . . .  ". 
mapping of the integration site or study of the possible 
fu:g'=ional hcrations of these genes has been done. 
DNA of two l'i~1 1~.  HPV-|6 or I~ .ha~ bccn 
delected in lhc chromosomal ~on 8q24. The tumor 
~>1~ i~ variab~ and indt _~s_ ' two cet,'/cal aden<)- 
carcinomas [15]. one penile carcinoma [15]. the Hela cell 
line [13~4]. derived from a cervical adenocarcinoma. 
and an argyrophhyl ctql carcinoma [17]. This last type 
is particularly agn~sive. 
In all the cases o f  HPV integration in 8q24 there is 
an amplification o f  the viral DNA sequences Which 
ranges from 5 to 50 copies and are usually forming a 
head to tail array. On the other hand the status of  the 
e-re)x" gene is very variable. In only one case there is 
amplification of  c-myc [15]. With the exception of  the 
penile carcinoma there is no rearrangement of he c-myc 
gene [15]. This observation implies that the integration 
takes place at a significant distance from the c-myc gene. 
In two cases there is overexpression f  c-myc, but this 
overexpression has no correlation with the level of  HPV 
DNA amplification. A threefold increase in expression 
is detected whether there is no integration, or the am- 
plification ranges from five to fifty copies of  integrated 
~4ral DNA [13,15,17,24]. In the Hcla cell line there is a 
light increase in myc RNA levels line consistent with its 
constitutive expression [13,24]. Further studies promise 
to shed more light on the role of the 8q24 region in 
human oncogenesis. The lack of a correlation between 
the integration/amplification of HPV DNA and c-myc 
gene makes it unlikely that the effect on c-nwc is the 
main reason for the selection of these integrations. 
Obviously c-myc does play a role, like in many other 
tumors, but this is in addition to the effect of  the viral 
integration in the same chromosomal region. A can- 
didate gene might be located in the pal-1 locus, the in- 
tegration site of HPV-18 DNA in Hela cells [19,24]. 
from which two messages have been detected in some 
tumor cell lines like Colo320 [24]. HL-60 [24] and some 
Burkitt's lymphomas (E.F. an_ a P.A.L., unpublished), 
Other lines of research also support he involvement 
of the chromosomal region 8q24. In experiments involv- 
ing the immortalization of human keratynocytes with 
HPV-16 there is an amplification of the c-myc region 
without rearrangement of his gene [25]. In this cell line, 
WI2. the integrated viral DNA is amnlified to the same 
extent as c-myc, but no linkage was es,~ ~iisbed between 
the two [25]. Some other reports have been published 
describing structural alterations 5" from c-myc in papil- 
lomavirus induced tumors, but no correlation was done 
regarding the integration of the virus [25,26]. In animal 
models, like transgenic mice with BPV-I. viral integra- 
tion have been found in mou~ chromosome 15 which. 
interestingly enough, is syntenic to human chromosome 
8 [27 I. 
!2q13 IS ANOTHER COMMON REGION OF 
INTEGRATION 
The other common chromosomal region of integra- 
tion. 12q!3. is also a region associated with a large 
variety of tumors [28]. In this chromosomal region there 
are three knotT= oncogenes, inl-l, gli- I. a mcm_h~r, of the 
|aO 
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Kruppel family, and rap l  B, a member of  the ras family 
• [28], Another interesting gene in the region codes for the 
melanoma antigen ME491 [29,30]. This antigen belongs 
to a family of  genes with antiprolifemtive properties 
[30], thus melanomas with high levels of  this antigen 
have a much better prognosis titan those with low levels 
of  ME491 [29]. These antigens are expressed in tumors 
ofepithdial  origin which makes this antigen a possible 
candidate for alterations in cervical carcinoma. 
Nevertheless this possibility has yet to he explored. Two 
cell lines, SW756 [20] and SK-v [14], have integrated 
HPV-18 and HPV-16 DNA, respectively. The  genes 
int- I  or gl i - I  are not  affected by  the integrated vital 
DNA in the case of  $K-v cell line [12]. and they have 
not been studied in the case of SW756 calls. In the SK-v 
cell line this integration was already present in the  early 
stages of  the original tumor, the premalignant lesion, 
suggesting that it might play a role that early in the 
process [I2]. In either case, we do not know what the 
proximity of  HPV sequences to these oncogenes i . It is 
likely that other tumorigenic genes, not yet identified, 
are located in this chromosomal region. 
Table I
Human papillomavirus integration regions 
Tumor or cell line (CL) Vit~al type Chromosomal Genes Other tumor phenotypes linked to this region 
location 
Squamous cell carcinoma [15} HPV- 18 2p24 N-no'c Neurob|astoma 
FRA2C Lung carcinoma 
Cervical carcinoma [17] HPV.18 3p21-22 erhA2 
Cervical carcinoma h, v-1O 3q25 raT:l 
Hela tCL) [13,16,21] HPV-18 5pll-15 ab.,,rmal FRA5A and iS. 
mh'i-2, GHR 
C4-1 {CLI [18,23] HPV-I8 8q22 myb-B 
FRAI8A and B 
Cervical adeno~mrcinoma [15] HPV-18 8q24 c-rare pal- I, mh'i-I 
and 4, FRAI8C. 
D and E 
Cervi~:al denocarcinoma 1!5} HPV-16 8q24 ibid. 
Penile carcinoma [151 HPV-16 8q24 ibid. 
Argyrophil small cell carcinoma [17] HPV-16 8q24 ibid. 
Hela tCL} [13.t6.21,24] HPV,18 8q24 ibid. 
Hela (CL~ 113.16.21] HPV-18 9q31-q34 c.,ht. 
FRAgB and E 
SK-v tCL¿ II41 HPV-16 1_2q13 uu- 1, gh- I. 
ME491. rupl IL 
FRAI2 A. 
homco box 3 
SW 756 ICL112111 HIW-IS 12q13 ibid, 
SiHa {CL11211 HPV.16 13q2t-31 FRAIMt. C, exiision 
repair t!<R(" ('~! 
~"~ 2-ql~ l'l)fil', X.r+'+ Hda l('l.l Ii kl+,211 III'V-IS _.ql 
ahnor tna~ homolog. N I -  
I IF. MG('R. 
hal-2, l:RA22A 
Tl'¢ data on gcnc k'~:ali~m i~ ba~cd on lhe IIIIh Hum;m (lone MappinLt ()ollfefcm,~ [28[. 
Non-Hodgkin's lymphoma, pleomorphic 
adenoma, denocarcinoma (kidney. O*aD'l. 
lung carcinoma 
Adenocarcinoma 
Acute mycloid leukemia 
Burkitt's lymphoma, acme lymphoblastic: 
leukemia, malignant lymphoma, familial renal 
carcinoma 
ibid. 
ibid. 
ibid. 
ibid. 
AML. CML. ALL 
Melanoma. lipoma, lipo~rcoma, g.lmma. 
[ciolnyo~illrCOnla, pteomorphic adenoma. 
T-cell lymphom:t 
ibid. 
%,11"~111tI .~ '~ ~|L 
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Ta~ II 
Fmgak~ flgenet lo~md i~ ~ tm%~tti~a sites of human 
t ,~  vir~m 
cm~lh fagt~ 
R;F-2 F~ 
/at-I 
LIF /~-2 
G,~, .~ fam~ ~ ~  kmasm 
Pa~samme reaWa~ c-~ 
T~.~id lanmoae nx~of 
Ga~lh hommae mx~to~ 
NF~ mm 
pma~ Ifiaa~C erbA2 
M~n~ proz~ 
ME491 Thy-I 
CD~ CD3 
CiY3 CD20 
Nuclear . . . .  fa~ors: 
glM 
N-m3. r aki 
¢¢x-i e&-l 
c3~:tin A 
Ptmeaseg 
saemebm 
colla~ .12~nas¢ 
Tumor sa~gtnessor gene~ 
p$3 MEN.I 
~-r. I  
mir/-! b¢l- I 
bcl-2 
/~f-I CBL-2 
MGCR 
carcinoma is in the range of 10-20 percent of  the cases. 
This ftx~quency is the ~e found for:many loci impli-: 
cared in ~ b y  nowtransforming retrovimses 
IS], and suggests that all of  them might play a similar 
role in the pathogenesis of  the dL ~?~ 
FUNCTION OF GENES AFFECTED BY DNA 
VIRUS INTEGRATION 
In all the cases tudied, the location of the integrated 
pap~lomavims DNA (Table I) or hepatitis B virus 
DNA [31] correlates very well with either chromosomal 
regions associated with other tumor pathology or with 
chromosomes fragile sites [223]. 
We can look at the integration sites from the point of 
view of the function of  the genes located in these chro- 
mosomal regions (Table II). The putatively affected 
genes can be functionally classified in several categories 
like genes coding for growth factors, growth factor re- 
ceptors, membrane or cytoplasmic proteins involved in 
signal transduction, and nuclear proteins most of  which 
arc known to have transcription factor activity. Also 
other genes potentially implicated in the dissemination 
of the tumor+ like protcases, might be affected. In the 
data shown in Table It there are twenty-five oncogenes, 
three supressor genes and several other genes the func- 
tion ofwhich is related to that ofknown oncogenes, like 
several growth factor eceptors. It is important to notice 
that these genes arc the same that can be affected in 
oncogenesis by non-transforming :etroviruses [8]. Me- 
chanistically the imegrated viral DNA is likely to alter 
these genes in a fashion similar to the non transforming 
retroviruscs implicated in oncogenesis, most likely by 
an cnhancher insertion mechanism [7.8]. 
RELATION WITH THE INTEGRATION SITES OF 
OTHER HUMAN TUMOR VIRUSES 
Hepatitis B virus is tinkcd to the de~'elopment of  
hepatocellular carcinoma [31]. Two common regions of 
integrat;on have so far been d~.~ed in Ig'i~loccllular 
carcinoma cases, I lq13 and Xp22. where inlegrated 
viral DNA has been found in two tumors (reviewed in 
|31]). The I lq13 region has several oncogenesis-related 
genes like bcl-l, hst-l./nt-2 and MENd (multiple en- 
docrine ncoplas;.a). The Xp22 region contains the c~-! 
gone which is related to the ets-! family of transcription 
factors [32]. The ezs-I gcn¢ ilsclf, the Iranscr/pfion 
factor PEA3 [33]. is the target of HBV integration in 
another tumor. There is also a chromosomal location. 
12q 13. which is also the integration tarl~ of hepatitis 
B ;~pd~ [:tl] a~, HP%' [14A'~d]. thus iwo types of viruses 
can be found m this interesling ¢hromosomel legion. 
Based on the data oct HPV (this ¢~ort ) and HVB |31 ]
~ f rcqu~-  of finding a common chromosomal 
alte~at~ in 6thor ~- i¢~ ¢ar~/noma or hepatoceIlular 
CONCLUSION 
Human papillomavituscs and human hepatitis B 
virus by persisting a long time as ~ chr',nic infection in 
epithelial or hepatic ells, respectively. ~.~ve ":~, poten- 
tial for occasional integration in the cellular genome. 
Some viral DNA integrations might be selected for the 
consequences onthe tumor phenotyp¢, which might be. 
an early or late tumorigenic event. It is our view- that 
integrated HPV and HBV DNA are markers for the 
location of  genes implicated in the tumor phenotype, in
a way similar to the non-transforming retroviruses. All 
the chromosomal integration regions o far identified 
vdth bolh viruses are consistent with this view. Taking 
into account the small number of cases tudied in both 
dLscases, it is highly likely that these common integra- 
tion sites, cither for one type of virus or bo'.h, are the 
result of strong biological selection for some properties 
of the tumor octl wh~:h remain !o be discovered. In- 
tegrated viral DNA can thus be an important :ool in the 
8J2 
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search of human genes related to oncogenesis which 
otherwise would be extremely difficult to identify. 
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